Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $157000.0.

  • Niagen Bioscience's Depreciation and Depletion fell 426.83% to $157000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $624000.0, marking a year-over-year decrease of 943.4%. This contributed to the annual value of $663000.0 for FY2024, which is 2379.31% down from last year.
  • Per Niagen Bioscience's latest filing, its Depreciation and Depletion stood at $157000.0 for Q3 2025, which was down 426.83% from $158000.0 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Depreciation and Depletion registered a high of $235000.0 during Q3 2022, and its lowest value of $151000.0 during Q4 2024.
  • Over the past 5 years, Niagen Bioscience's median Depreciation and Depletion value was $211000.0 (recorded in 2021), while the average stood at $198157.9.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 1343.28% in 2023, then plummeted by 2961.37% in 2024.
  • Niagen Bioscience's Depreciation and Depletion (Quarter) stood at $211000.0 in 2021, then rose by 4.74% to $221000.0 in 2022, then dropped by 19.91% to $177000.0 in 2023, then decreased by 14.69% to $151000.0 in 2024, then grew by 3.97% to $157000.0 in 2025.
  • Its last three reported values are $157000.0 in Q3 2025, $158000.0 for Q2 2025, and $158000.0 during Q1 2025.